EQS-News: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients Seite 1

08.02.2023 - EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients 08.02.2023 / 14:00 CET/CEST The issuer is solely ... Seite 1

Related Keywords

Germany ,Montreal ,Quebec ,Canada ,Munich ,Bayern ,Lamab Biologics ,Caroline Fortier ,Mark Cipriano ,Life Science Innovation Ii Fund ,Science Innovation ,Life Science ,Sascha Berger ,General Partner ,Marc Rivi ,Eqs News ,